Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

Amy Schumer recently took to her Instagram handle to share her experience with Midi Health. The 43-year-old actress-comedian ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also ...

The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a ...

Blood sugar was once considered something people only focused on when they had diabetes. But the explosion in popularity of medications that affect blood sugar, like Ozempic and Wegovy, along with ...

Amy Schumer has revealed that she's back on a new weight loss drug after her "horrible experience" with Wegovy.

The latest microdosing trend isn’t shrooms or acid. It’s Ozempic.

Mounjaro’s been great,” the comedian said in an Instagram video. “I’m having a really good experience with it and I wanted to ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Drugmakers are urging the Trump administration and EU officials to exclude medical goods from expanding tariffs wars ...

My son has been overweight his whole life. He is now obese and is asking if he could take the medicine he sees on TV ...